Description
Chumulin M3 (Insulin) Suspension for Injections 100 IU/ml. 3 ml. Cartridge №5
Ingredients:
Chumulin M3 contains insulin as the active ingredient. Other ingredients include suspending agents, preservatives, and pH adjusters.
Mechanism of Action:
Insulin promotes the uptake of glucose into cells, reducing blood sugar levels. Chumulin M3, as a suspension formulation, offers a prolonged effect, aiding in maintaining stable glucose levels over an extended period.
Pharmacological Properties:
Chumulin M3 exerts its pharmacological effects by regulating glucose metabolism. It facilitates glucose uptake by peripheral tissues, inhibits hepatic glucose production, and enhances protein synthesis.
Indications for Use:
Chumulin M3 is indicated for the treatment of diabetes mellitus to control hyperglycemia and maintain optimal blood sugar levels.
Contraindications:
Chumulin M3 is contraindicated in individuals with a known hypersensitivity to insulin or any of the product components. It should not be used during episodes of hypoglycemia.
Side Effects:
Common side effects of Chumulin M3 may include hypoglycemia, injection site reactions, allergic reactions, and lipodystrophy.
Usage Instructions:
Chumulin M3 should be administered subcutaneously following individualized dosage recommendations provided by a healthcare professional. Rotate injection sites to prevent lipodystrophy.
Benefits Compared to Analogues:
Chumulin M3 offers comparable efficacy to other insulin formulations in managing blood glucose levels. Its suspension form provides a sustained effect, reducing the frequency of injections required.
Suitable Patient Groups:
Chumulin M3 is suitable for use in both pediatric and elderly populations under appropriate medical supervision. Dosage adjustments may be necessary based on individual patient needs.
Storage and Shelf Life:
Store Chumulin M3 as per the manufacturer’s instructions. Avoid exposure to extreme temperatures. Check the expiration date on the packaging and do not use expired cartridges.
Packaging Description:
Chumulin M3 is available in 3 ml cartridges, with each package containing 5 cartridges. The packaging is designed to maintain product integrity and sterility.
Scientific Evidence:
Studies have demonstrated the efficacy of Chumulin M3 in controlling blood glucose levels in patients with diabetes. Research published in reputable journals has highlighted the effectiveness of insulin suspensions like Chumulin M3 in improving glycemic control.
Clinical Trials: Clinical trials comparing Chumulin M3 with other insulin formulations have shown similar efficacy in glycemic control. Research studies have shown promising results in blood sugar management with the use of Chumulin M3.
